Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer
返回论文页
|更新时间:2023-05-16
|
Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer
Genes & DiseasesVol. 10, Issue 2, (2023)
作者机构:
1. Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University,Chongqing,China,400016
2. Department of Oncology, The Second Affiliated Hospital of Chongqing Medical University,Chongqing,China,400016
3. Cancer Epigenetics Laboratory, Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Center for Cancer, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong and CUHK Shenzhen Research Institute,Guangdong,Shenzhen,China,518172
4. Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital,Chongqing,China,400030
Shuman Li, Xiaoqian He, Yan Wang, et al. Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer. [J]. Genes & Diseases 10(2).(2023)
DOI:
Shuman Li, Xiaoqian He, Yan Wang, et al. Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer. [J]. Genes & Diseases 10(2).(2023) DOI: 10.1016/j.gendis.2021.12.019.
Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer
摘要
Abstract
Our previous studies found that Zinc-finger protein 382 (ZNF382) played as a tumor suppressor gene in esophageal and gastric cancers
and a positive correlation between the high expression of ZNF382 and better outcome in breast cancer patients. However
the biological roles and mechanisms of ZNF382 in breast cancer remains unclear. We detected ZNF382 expression by reverse-transcription PCR (RT-PCR) and real-time quantitative PCR (qRT-PCR) in breast cancer cells and tissues
and explored the impacts and mechanisms of ectopic ZNF382 expression in breast cancer cells
in vitro
and
in vivo
respectively. Our results revealed that ZNF382 was significantly down-regulated in breast cancer tissues compared with adjacent non-cancer tissues. Restoration of ZNF382 expression in silenced breast cancer cells not only inhibited tumor cell colony formation
viability
migration and invasion
and epithelial-mesenchymal-transition (EMT)
but also induced apoptosis and G0/G1 arrest. In conclusion
ZNF382 could induce G0/G1 cell cycle arrest through inhibiting CDC25A signaling
and
inhibit cell migration
invasion and EMT by antagonizing ZEB1 signaling in breast cancer cells.
Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine
LKB1 depletion-mediated epithelial–mesenchymal transition induces fibroblast activation in lung fibrosis
Mitochondria-related signaling pathways involved in breast cancer regulate ferroptosis
Zinc finger protein 831 promotes apoptosis and enhances chemosensitivity in breast cancer by acting as a novel transcriptional repressor targeting the STAT3/Bcl2 signaling pathway
A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis
Related Author
Farzad Sadri
Seyede fatemeh Hosseini
Zohreh Rezaei
Mohammad Fereidouni
Zijian Xu
Elizabeth R. Davies
Liudi Yao
Yilu Zhou
Related Institution
Tabas School of Nursing, Birjand University of Medical Sciences, Birjand 971785
Department of Biology, University of Sistan and Baluchestan, Zahedan 981674
Student Research Committee, Birjand University of Medical Sciences, Birjand 971785
Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand 971785
Institute for Life Sciences, University of Southampton